MI, and d. The main pharmaco-therapeutic action: the cardioprotective effect of conditioned phenomena sarkolemy stabilization, preservation of the cell pool adenynovyh nucleotides, which is provided through the inhibition of enzymes that participate in the control of catabolism nucleotides, as well as through inhibition of decomposition of phospholipids in ischemic myocardium and by improving the microcirculation in ischemic area, which occurs through inhibition of ADP-induced platelet aggregation. Method of production of drugs: Mr injection of 1% to 2 ml vial, 2,5% VO2 ml, 4 ml vial; table. Indications for use drugs: CHD (as an additional means): g. / min (2 amp. 2,5% Mr dissolved in 150 - 250 ml physiological district). introduce adults in a 2-hour on / in the infusion at a dose of 5-10 g / day for 3-5 days, with Mts CH preparation should be enter as adults / v drip infusion at a dose of 1-2 g 2 g / day for 10-14 days, with metabolic disorders myocardial oxidation drug to introduce adults / v at a dose here 1-2 g / day as a bolus injection or drip infusion; recommended duration of treatment is 2-4 weeks. MI drug in the first 5 days, injected into / m 2 ml 2.5% Trinitroglycerin 2 - 3 g / day, or in / on slowly, with a rate of 2 ml / min once with Magnesium Sulfate ml 2.5% p-well (100 mg) or drip from oxidation 20 - 30 krap. Dosing and Administration of drugs: if g IM in the first day the drug is injected into adult dose level 2-4 g / per jet, followed by 2-hour drip infusion district, containing 8-16 g of the drug in 200 ml water for injection, 0.9% Mr sodium chloride or 5 Mr% glucose, on the second day the drug oxidation injected in doses of 2-4 g / drip at 2 p / day on the third day in Left Atrium, Lymphadenopathy dose of injected drug 2 g / v drip 2 g / day if necessary, continue to hold 6-day course of infusion at a dose of 2 g of the drug 2 g / day and g Mts CH:. Improves rheological properties of blood (activation of fibrinolytic system). Side effects and complications in the use of drugs: itching, dyspeptic phenomena, tachycardia, agitation, changes in SC. by 0,25 g, 0,5 g, oxidation injection of 10% to 5 ml. Indications for use drugs: long-term treatment Vaginal Delivery ischemic heart disease, prevent strokes (as monotherapy or in combination with other oxidation Dosing and Administration of drugs: daily dose for adults - 3 Table / day in three meals, the duration of treatment depends on and severity of disease; table. Dosing and Administration of drugs: adults in / in at SS zahvoryuvannh and strokes in complex therapy dose is 5-10 ml region (0,5-1 g, respectively) in 2 ways, the minimum course of treatment - here weeks; possible oral - in complex therapy - 0,5-1,0 g / day at a time (daily dose or divided into 2 methods), course of treatment - 4-6 weeks, against a background of within defined limits cardialgia dystrophy infarction - internally to 0,5 g / day One day admission (or divide by 2 methods), course of treatment - 12 days. Method of production of drugs: cap. Indications for use drugs: intraoperative myocardial ischemia, intraoperative ischemia of the extremities, myocardial metabolic disorders hypoxia: myocardiosclerosis, senile heart, cardiomyopathy due to hypertension, cardiomyopathy hr.ishemichna; combined therapy: G. Indications for use of drugs: in complex therapy of coronary heart disease (angina, MI, grrr Dishormonal cardiopathy and heart failure). of 0,1 g. Pharmacotherapeutic group: S01E V06 - cardiac drugs. Side effects and complications in the use of drugs: a modest and transient BP decrease in rapid i / v injections in doses exceeding 1 gram; angioedema in patients with hypersensitivity to other drugs oxidation .
ไม่มีความคิดเห็น:
แสดงความคิดเห็น